MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2025 International Congress

    Engage- Qatar PD: The development of an online self-management intervention to promote engagement in physical activity for people with PD in Qatar

    H. Khalil, R. Hammad, M. Rawash, S. Pedersen, L. Morris, M. Choudhury, L. Quinn, A. Oun (Doha, Qatar)

    Objective: To develop the Engage-Qatar PD self-management intervention with cultural-adaptations for people with PD in Qatar. Background: Many people with PD engage in insufficient exercise…
  • 2025 International Congress

    Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)

    Objective: To evaluate the frequency of depression in a group of patients diagnosed with IPDWD, assessed by a new ESDEPARK scale that specifically measures depressive…
  • 2025 International Congress

    A Survey On The Changes Of Non-Motor Symptoms And Quality Of Life In Patients With Parkinson’s Disease After Bilateral Subthalamic Nucleus Deep Brain Stimulation

    J. Wang, D. Zhu, Y. Gao, L. Wang, D. Li, B. Sun, Y. Wu, X. Qiu (Shanghai, China)

    Objective: This study aims to explore the trajectory of non-motor symptom (NMS) changes in Parkinson's disease (PD) patients after bilateral subthalamic nucleus (STN) deep brain…
  • 2025 International Congress

    Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention

    J. Acquaviva, S. Maguire, Y. Xu, E. Feinstein (Newark, USA)

    Objective: To identify various non-motor symptoms experienced by individuals with PD and to assess the likelihood of these symptoms being treated relative to individuals without…
  • 2025 International Congress

    Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)

    Objective: To analyze the impact of anxiety on self-perception of health in patients with Idiopathic Parkinson's Disease Without Dementia. Background: After depression in Idiopathic Parkinson's…
  • 2025 International Congress

    Sexual Health Decline in Women with Parkinson’s Disease: A Two-Year Follow-Up Study

    T. Silva, K. Nobrega, ME. Piemonte (Sao Paulo, Brazil)

    Objective: To investigate the long-term decline in sexual health among women with Parkinson’s disease (PD) over a two-year period. Background: Sexual dysfunction (SD) is a…
  • 2025 International Congress

    The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease

    N. Duff, C. Cawood, M. Noble (Parktown, South Africa)

    Objective: To determine the motor and non-motor benefits of WB-EMS in a patient with Parkinson’s disease Background: Parkinson’s disease causes both motor and non-motor symptoms.…
  • 2025 International Congress

    The Complexity of Neuropsychiatric Symptoms Assessment in Parkinson’s Disease: A Rasch Analysis of the Mild Behavioral Impairment-Checklist

    Y. Song, L. Ronat, O. Monchi, Z. Ismail, G. Pinilla-Monsalve (Montreal, Canada)

    Objective: This study aims to evaluate the psychometric properties of the Mild Behavioral Impairment-Checklist (MBI-C) in Parkinson’s Disease (PD) using Rasch measurement theory. Background: The…
  • 2025 International Congress

    Structural changes in the retina and their correlation with the severity of non-motor symptoms in patients with Parkinson’s disease.

    A. Alcocer-Salas, A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)

    Objective: To evaluate the association between retinal structural changes, as measured by optical coherence tomography (OCT), and non-motor symptoms severity in patients with Parkinson’s disease…
  • 2025 International Congress

    Relationship Between Improvement in “On” Time, Nonmotor Symptoms, and Quality of Life in Adults Treated With Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease

    K. Chaudhuri, P. Odin, J. Aldred, L. Bergmann, J. Homola, R. Gupta, A. Antonini, M. Soileau (Spokane, USA)

    Objective: To determine if adults with advanced Parkinson’s disease (aPD) treated with a 24‑hour/day continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) infusion who had ≥ 1‑hour improvement in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley